Akthelia News Desk
Akthelia Pharmaceuticals featured in Icelandic newspaper Viðskiptablaðið
Akthelia Pharmaceuticals is featured in today's edition of the leading Icelandic business newspaper Viðskiptablaðið.
top of page
Akthelia News Desk
Oct 17
Akthelia Pharmaceuticals Awarded RANNIS Grant to Accelerate Development of Gastrimod® (AKT-011) for Chemotherapy-Induced FN
Akthelia Pharmaceuticals is pleased to announce it has been awarded a two-year $350,000 research grant by RANNIS
Akthelia News Desk
Sep 8
Akthelia Pharmaceuticals presents new translational mucosal barrier injury efficacy data at NLSD 2024
Akthelia Pharma will present exciting new translational data, and partnering and capital raising objectives at Nordic Life Science Days 2024
Akthelia News Desk
Apr 6
Akthelia receives European Commission Seal of Excellence
Akthelia Pharmaceuticals announce its award of the European Commission Seal of Excellence, a quality recognition by the European Union.
Akthelia News Desk
Apr 5
Meet Akthelia Pharmaceuticals at the LSX World Congress 2024
Akthelia Pharmaceuticals is at a pivotal juncture, with a strongly validated and developable lead asset, ready to enter IND-enabling studies
Akthelia News Desk
Nov 27, 2023
Dr Sonja Srdanović joins Akthelia Pharma as R&D Program Manager for Inflammation and Infection
Dr Sonja Srdanović joins Akthelia Pharma as R&D Program Manager for Inflammation and Infection
Akthelia News Desk
Oct 30, 2023
Meet Akthelia Pharmaceuticals at Nordic Life Science Days, 2023
Akthelia Pharmaceuticals will attend the Nordic Life Science Days Summit in Copenhagen, 9 - 30 November 2023 REYKJAVIK, Iceland -- 30...
Akthelia News Desk
Oct 25, 2023
Dr Helga Einarsdóttir joins Akthelia Pharma as R&D Program Manager for Wound Therapeutics
Helga Kristín Einarsdóttir joins Akthelia as R&D Program Manager for Wound Therapeutics.
Akthelia News Desk
Apr 17, 2023
Akthelia Pharmaceuticals and the University of Iceland Secure a €6M EU Horizon Grant
Akthelia Pharmaceuticals and the University of Iceland Secure a €6M EU Horizon Grant to Combat Antimicrobial Resistance (AMR)
Akthelia News Desk
Dec 12, 2022
Akthelia Pharmaceuticals is selected to present at the Science4Peace Summit in Stockholm
Akthelia Pharma selected to present at the Science4Peace Summit in Stockholm, Dec 2022
Akthelia News Desk
Aug 31, 2022
Akthelia Pharmaceuticals Participates in the LSX Leaders Nordic Congress 2022
Akthelia Pharmaceuticals Participates in the LSX Leaders Nordic Congress 2022
Akthelia News Desk
Jun 29, 2022
Akthelia Pharmaceuticals Announces Second Close of Follow-Up Pre-Seed Equity Round
Akthelia Pharmaceuticals Announces Second Close of Follow-Up Pre-Seed Equity Round
Akthelia News Desk
Jan 20, 2022
Akthelia Pharmaceuticals Announces Close of Follow-Up Pre-Seed Equity Round
Akthelia Pharma Announce Close of Follow-Up Pre-Seed Equity Round
Akthelia News Desk
Sep 1, 2021
Dr Steingrímur Stefánsson joins Akthelia Pharma in the role of Senior Scientist
Highly experienced research scientist Dr Steingrímur Stefánsson joins Akthelia to boost R&D capabilities
Akthelia News Desk
May 31, 2021
Akthelia Pharma is awarded a RANNÍS grant for wound healing
RANNÍS, the Icelandic technology fund, has awarded Akthelia Pharma $330,000 for the initial development of its novel wound healing approach.
Akthelia News Desk
Aug 31, 2020
Akthelia Pharma Announces Close of a Pre-Seed Equity Round
Akthelia Pharma Announces Close of a Pre-Seed Equity Round
Akthelia News Desk
Jun 14, 2019
Akthelia Pharma is awarded a RANNÍS grant towards a POC of its innate immunity approach
RANNÍS, the Icelandic technology fund, has awarded Akthelia Pharma $330,000 to develop a proof of concept
Akthelia News Desk
Jan 28, 2019
Akthelia will attend the 2019 ANTIMICROBIAL PEPTIDES GORDON RESEARCH CONFERENCE
Akthelia will attend the 2019 ANTIMICROBIAL PEPTIDES GORDON RESEARCH CONFERENCE
bottom of page